Carregant...

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic

In the last decades, the increasing evidence concerning inflammation mechanisms underlying severe eosinophilic asthma has highlighted new potential therapeutic targets and has paved the way to new selective biologic drugs. Understanding the mechanism of action and the clinical outcomes of a particul...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biologics
Autors principals: Caminati, Marco, Bagnasco, Diego, Vaia, Rachele, Senna, Gianenrico
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6535408/
https://ncbi.nlm.nih.gov/pubmed/31190733
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S157183
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!